Larvol Delta - Inclisiranbased-treatment-strategy-in-very-high-cardiovascular-risk-patients-with-statin-intolerance-Is-the-game-worth-the-candle

Leqvio (inclisiran) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42484610

Beatrice Dal Pino; Francesco Sbrana

Jul 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next